WO2020055433A1 - Devices and methods for remodeling tissue - Google Patents
Devices and methods for remodeling tissue Download PDFInfo
- Publication number
- WO2020055433A1 WO2020055433A1 PCT/US2018/051211 US2018051211W WO2020055433A1 WO 2020055433 A1 WO2020055433 A1 WO 2020055433A1 US 2018051211 W US2018051211 W US 2018051211W WO 2020055433 A1 WO2020055433 A1 WO 2020055433A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- engagement members
- electrodes
- spacing
- energy
- applying
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
- A61B18/12—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
- A61B18/14—Probes or electrodes therefor
- A61B18/1492—Probes or electrodes therefor having a flexible, catheter-like structure, e.g. for heart ablation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00053—Mechanical features of the instrument of device
- A61B2018/00214—Expandable means emitting energy, e.g. by elements carried thereon
- A61B2018/0022—Balloons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00053—Mechanical features of the instrument of device
- A61B2018/00214—Expandable means emitting energy, e.g. by elements carried thereon
- A61B2018/00267—Expandable means emitting energy, e.g. by elements carried thereon having a basket shaped structure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00315—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body for treatment of particular body parts
- A61B2018/00345—Vascular system
- A61B2018/00351—Heart
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00571—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body for achieving a particular surgical effect
- A61B2018/00577—Ablation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
- A61B18/12—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
- A61B18/14—Probes or electrodes therefor
- A61B2018/1405—Electrodes having a specific shape
- A61B2018/1425—Needle
- A61B2018/143—Needle multiple needles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
- A61B18/12—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
- A61B18/14—Probes or electrodes therefor
- A61B18/1442—Probes having pivoting end effectors, e.g. forceps
- A61B2018/146—Scissors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
- A61B18/12—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
- A61B18/14—Probes or electrodes therefor
- A61B2018/1475—Electrodes retractable in or deployable from a housing
Definitions
- the present technology relates to RF devices used to remodel tissue.
- the device and methods disclosed herein have broad applicability to shrink collagenous tissue, and in particular they are well suited for remodeling cardiac tissue (e.g., a cardiac valve annulus and the chordae tendineae) to reduce regurgitation though the valve and enhance valve competency.
- cardiac tissue e.g., a cardiac valve annulus and the chordae tendineae
- Mitral annular dilatation is a common feature of mitral valve disease, especially in functional or secondary mitral valve disease. As the annulus dilates, the leaflets are pulled apart until the edges no longer coapt in systole resulting in regurgitation. Reducing the overall circumference of the annulus is one of the most common elements of successful surgical mitral valve repair. This can be surgically performed by sewing the mitral annulus to an annulop!asty ring having a smaller diameter than the annulus. This permanently reduces the mitral annular circumference, but it entails an open or minima!ly-invasive surgical procedure involving significant trauma, morbidity, and recovery time.
- a minimally invasive method for reducing the size of a cardiac valve annulus in a beating heart comprising:
- the at least two electrodes may be configured to seif-extend away from each other when unconstrained, and wherein increasing a spacing between the two electrodes includes allowing the two electrodes to self-extend away from each other
- increasing a spacing between the two electrodes includes actuating a mechanism to actively increase the spacing between the two electrodes.
- the two electrodes include a first electrode and a second electrode, and the method includes:
- applying an approximating force includes advancing a sheath catheter toward the at least two electrodes.
- applying an approximating force includes deflating the bladder between the electrodes
- applying an approximating force includes actuating an approximating mechanism to actively decrease the spacing between the two electrodes.
- a minimally invasive method for selectively reducing the dimensions of a cardiac valve tissue in a beating heart comprising:
- the engagement members include a first engagement member and second engagement member
- the method further comprises: a. withdrawing the first engagement member from the annulus cardiac tissue while leaving the second engagement member embedded in the cardiac tissue;
- moving at least one of the engagement members along an approximating path includes advancing the catheter toward the engagement members
- moving at least one of the engagement members along an approximating path includes actuating an approximating mechanism to actively decrease the spacing between the engagement members.
- applying energy includes applying an energy modality selected from the group of (bipolar, monopolar, resistive heating, ultrasound, laser, and microwave).
- a minimally invasive device for reducing the diameter of a cardiac valve annulus in a beating heart comprising:
- tissue shrinking component configured to deliver at least one of energy and a chemical agent between the two engagement members
- approximation mechanism configured to apply a force to the engagement members, wherein the force is selected from the group of an approximating force and a separating force.
- the tissue shrinking component comprises an energy delivery mechanism configured to deliver an energy modality selected from the group (bipolar, resistive heating, ultrasound, laser, and microwave).
- the tissue shrinking component comprises a chemical agent is selected from the group of (phenol, and glutara!dehyde)
- the tissue shrinking component is operably connected to the engagement members.
- the approximation mechanism includes a linkage connecting the engagement members.
- the linkage may include a hinge.
- the approximation mechanism includes a pull-wire connected to the linkage such that pulling on the pull-wire applies an approximation force to the engagement members.
- the approximation mechanism includes a sleeve surrounding at least a portion of the engagement members, and wherein advancing the sleeve biases the engagement members together.
- FIG. 1 depicts an energy delivery device
- FIG. 2 depicts an energy delivery device
- FIG. 3 depicts an energy delivery device
- F!Gs. 4A-4D depict an energy delivery device and a method for shrinking cardiac tissue in a selective direction
- F!Gs 5A-5D depict a method for shrinking cardiac tissue in a selective direction
- FIG. 8 depicts an energy delivery device
- F!Gs. 7A-7C depict optional features of the energy delivery device of F!Gs. 1-3;
- FIG. 8 depicts an energy delivery device.
- the present technology is useful for shrinking collagenous tissue in general, and it is particularly useful for shrinking cardiac tissue, such as the annulus of a cardiac valve and/or the chordae fendineae, in a controlled, predictable manner to reduce regurgitation through the valve.
- the collagenous tissue in the annulus is surrounded by other tissue, such as muscle, which is not as likely to shrink when heated.
- existing mitral annuloplasty techniques may not shrink the collagen fibers in a desired manner.
- the present technology is expected to overcome the drawbacks of existing mitral annulop!asty techniques by grasping the cardiac tissue and approximating if in the desired direction of shrinkage. Energy is applied to the tissue either during or after approximating the tissue.
- the desired shrinkage may be in a circumferential direction (e.g., around the cardiac valve annulus), or it may be in another direction. Approximating the tissue reduces the tension experienced by the cardiac tissue thereby preferentially shrinking the collagenous tissue in the desired direction.
- the force approximating the tissue may be maintained briefly after terminating energy delivery. The tissue will shrink further in the desired direction than it would without pre-approximation, and it will retain more of the shrinkage in the desired direction after the energy has been applied and the device is removed.
- FIG. 1 depicts an energy delivery device 100 having a delivery catheter 120 and an optional guide catheter 122.
- the device 100 has a plurality of pin-shaped electrodes 102 (identified individually as a first electrode 102a and a second electrode 102b) at the distal end.
- the electrodes 102 can be independently advanced and/or retracted to insert them into and/or remove them from the annular tissue.
- the electrodes 102 may be advanced using a pushing motion (e.g., a push rod or push wire), and/or the electrodes 102 may have threaded surface 104 that engages and advances them into the annular tissue by rotation.
- a pushing motion e.g., a push rod or push wire
- the electrodes 102 may have an electrically conductive non-stick coating 106 so that they can be easily retracted from the tissue after heating the tissue.
- the electrodes 102 may be relatively stiff so that they resist bending when an approximating force is applied to puli the two electrodes together.
- the first and second electrodes 102a and 102b can be contained in individual guide tubes 108a and 108b, respectively, and the catheter 100 can further include an approximating mechanism 1 10 which can pull the guide tubes 108a-b together.
- the approximating mechanism can draw the guide tubes 108a- b together (i.e., approximate the guide tubes 108a-b) with sufficient force to overcome the naturally occurring tension in the tissue.
- the approximating mechanism 1 10 includes a pull-wire 1 1 1W that extends through the catheter and a hinge 1 12 proximal of the distal tip as shown in FIG. 1.
- the approximating mechanism 1 10 is connected by a linkage 1 14 configured to produce a linear approximating motion (indicated by arrows AL) between the first and second electrodes 102a and 102b to maintain a constant orientation between the first and second electrodes 102a and 102b as they are approximated.
- the approximating mechanism 1 10 in FIG. 2 can maintain a parallel relationship between the first and second electrodes 102a and 102b throughout the operational portion of the approximating motion in some embodiments, such as shown in FIG.
- the approximating mechanism 1 10 is a threaded mechanism 1 1 1 S having a worm gear (not illustrated), or the like.
- FIG. 3 illustrates the device 100 in which the approximating mechanism 1 10 includes a contraction member 1 18 around the first and second electrodes 102a-b and an expansion member 1 18 interposed between first and second electrodes 102a- b.
- the contraction member 1 18 pulls the two electrodes 102a ⁇ b together (approximated), while the expansion member 1 18 drives the electrodes 102a-b apart from each other.
- the contraction member 1 16 is an elastic sleeve and the expansion member 1 18 is a balloon 1 18 or the like.
- the expansion member 1 18 is configured to overcome the biasing force of the contraction member 1 18 for driving the electrodes 1 Q2a-b apart from each other.
- the expansion member 1 18 when the expansion member 1 18 is a balloon, Inflating the balloon with a fluid such as saline or the like will overcome the approximation force of the contraction member 1 16 and thereby further separate the electrodes 1 G2a-b from each other. Deflating the balloon by withdrawing some of the fluid from the balloon allows the approximation force from the contraction member 1 18 to overcome the expansion force of the balloon and thereby approximate the electrodes 102.
- the contraction member 1 18 can comprise one or more biasing members such as springs, elastomeric members, a worm gear or the like interconnecting the electrodes 1 Q2a-b and/or the tubes 108a-b instead of an elastic sleeve.
- biasing members such as springs, elastomeric members, a worm gear or the like interconnecting the electrodes 1 Q2a-b and/or the tubes 108a-b instead of an elastic sleeve.
- the catheters 100 shown in FIGs. 1-3 can further include a first sensor 130a at the first electrode 102a and a second sensor 130b at the second electrode 102b (collectively“sensors 130”)
- the sensors 130 can be impedance sensors or thermistors embedded into one or both of the electrodes 102.
- the sensors 130 can monitor the temperature or impedance of the tissue to determine the status of the tissue before, during and/or after applying energy to the tissue via the electrodes 1 Q2a ⁇ b
- the sensors 130 can send signals to a controller for ensuring electrode operation, ensuring electrode contact, controlling the extent of shrinkage, avoiding overtreatment, etc.
- the signals from the sensors 130 can be used to determine the total energy delivered to the tissue based on the relative spacing of the electrodes or estimate the distance between the electrodes.
- the electrodes 102a-b may be solid members (e.g., solid wires), or they may be tubes having a longitudinal lumen (e.g., hollow wires - not shown) and distal side-apertures (not shown).
- the lumens may extend through the full longitudinal length of the electrodes 102a-b, and the side-apertures may be in fluid communication with the lumens such that fluid introduced into the lumens exits through the apertures.
- a saline or hypertonic saline can be infused via the lumen and apertures while applying energy via the electrodes 102a-b to expand the effective area of heating and to control the extent of tissue desiccation at the electrodes 102a-b.
- the electrodes 1 Q2a-b can be cooled via circulation of fluid through them to prevent overheating of the electrodes while the intervening tissue is being heated.
- FIGs. 4A-4D illustrate an example of the operation of the device 100 shown in FIG. 1.
- the distal end of the energy delivery catheter 120 is first positioned near or against cardiac tissue such as the mitral valve annulus. (See FIG. 4A.)
- the energy delivery catheter 120 may be introduced to the left atrial surface of the annulus via a trans-septal or a trans-atrial approach, or it may be delivered against the ventricular surface of the annulus via a trans-aortic or a trans- apical approach.
- the energy catheter 120 or the guide catheter 122 may be manipulated to position the tip 120a of the catheter 120 near or in contact with appropriate annular tissue.
- the first electrode 102a is then advanced into the annular tissue, as shown in FIG 4A.
- the first or second electrodes 1 Q2a ⁇ b can be advanced into the annular tissue independently of each other, or they can be advanced into the tissue together.
- the electrodes 102 are exposed by unsheathing the energy delivery catheter 120 from the guide catheter 122 or extending the energy delivery catheter 120 from the guide catheter 122, and then withdrawing the energy delivery catheter 120 with respect to the tubes 108a-b. As the energy delivery catheter 120 is withdrawn, the electrodes 1 G2a-b can be self-biased to move further apart.
- the second electrode 102B can then be advanced into the tissue.
- An approximating force is applied to pull the two electrodes 1 Q2a ⁇ b together, which cinches the annulus tissue between the electrodes 1 G2a-b and thereby reduces the overall diameter of the annulus.
- the electrodes 102a-b might be inserted into the annular tissue spaced 10mm apart, and then pulled together to a separation of 2 mm-8 m, or 3 mm- 7 mm, or about 5 mm.
- the device 100 shown in FIGs. 4A-4C pulls the electrodes 1 G2a ⁇ b together using the pull-wire 1 1 1 W described above with reference to FIG. 1 , but the approximating mechanism can use a worm gear, linkage or the like as described above with reference to FIGs. 2 and 3 to approximate the two electrodes.
- energy is then applied between the electrodes 102a, 102b to heat the tissue for a desired time, (e.g , 15 seconds) until the collagen is adequately denatured so that the annulus retains the new smaller circumference.
- the energy may be bipolar RF energy, monopolar RF energy, laser energy, ultrasonic energy, resistive heating of the electrodes, microwave energy, or other energy modalities.
- the energy is applied based on the power and time to cause the desired amount of shrinkage without undesired disruption of the tissue.
- the energy can be applied at 10W-10QW, or 15W-85W, or 20W-70W, or 25W-55W, or 10W, 1 SW, 20W, 25W, SOW, 4GW, 45W, SOW, 55W, 60W, 65W, TOW, 75W, 80W, 85W, 90W, 95W or 100W, or any suitable wattage therebetween.
- the energy can be applied for 5s-3G0s, or 1 Gs ⁇ 240s, or 1 Gs-60s, or 10s, 15s, 20s, 25s, 30s, 35s, 40s, 45s, 50s, 55s, or 60s.
- a chemical agent e.g., phenol, glutaraidehyde or other fixative chemicals
- bipolar RF energy has the advantage of being naturally directed between the two electrodes for heating the tissue so that it shrinks in the desired area
- other energy modalities could also be applied.
- monopolar RF energy, laser energy, ultrasonic energy, resistive heating of the electrodes, microwave energy, or other energy modalities can be used with any of the catheters 100 described above in addition to or in lieu of RF energy.
- chemical methods could also be used to form the tissue into a desired shape, such as the injection of small amounts of phenol, glutaraidehyde or other fixative chemicals.
- FIG. 4A-4C can be repeated at different areas of the annulus to further reduce the circumference of the annulus in selected regions and thereby selectively reshape the annulus to promote coaptation.
- FIG. 4D for example, after the tissue has been approximated, heated, shrunk, and sufficiently cooled in a first region of the annulus, at least one of the electrodes 1 Q2a ⁇ b can be withdrawn from the tissue and moved to another section of annular tissue.
- the first electrode 102a can be removed from the tissue while the second electrode 102b remains in the tissue, and then the energy delivery catheter 120 can be (pivoted) rotated 180 degrees around the second electrode 102b such that the first electrode 102a is on the other side of the second electrode 102b.
- the first electrode 102a can then be advanced into the tissue at the new location such that the first and second electrodes 1 Q2a-b span a second region of the annulus adjacent to the first region.
- the treatment can then continue by applying energy to the second region of the annulus via the first and second electrodes 102a-b. In this manner, the catheter can be“walked” from one region of the annulus tissue to an adjacent region while remaining attached to the annulus at ail times. This is expected to make re positioning the electrodes 102a-b much faster and simpler.
- the guide catheter 122 can be used to position the energy delivery catheter 120 on or near the mitral annulus.
- the guide catheter 120 can be inserted into the femoral vein and advanced across the interatrial septum of the heart until a tip 122a of the guide catheter 122 is positioned in the left atrium.
- the energy delivery catheter 120 can be inside the guide catheter 122 at this point.
- the guide catheter 122 can then be flexed until the tip 122a is open towards a location on the mitral annulus.
- the energy delivery catheter 120 can then be advanced distaily through the guide catheter 122 until the electrodes 102 are at or near the mitral annulus.
- One or both of the electrodes 102a-b can be advanced into the annular tissue as described above with respect to Figure 4A.
- the guide catheter 122 can be withdrawn to allow the two electrodes to move laterally apart from each other.
- the energy delivery catheter 120 can be rotated until the second electrode 102b is positioned over the mitral annulus, and the second electrode 102b can be advanced into the annulus as described above with respect to 4B.
- the two electrodes 1 G2a-b can be pulled toward each other until they are spaced apart by a distance that places the tissue in a desired tensile state. Energy can then be delivered to the tissue via the first and second electrodes 102a-b.
- FIG 4D shows an example of the resulting annular shrinkage of the annulus.
- the catheters 100 described above with reference to FIGs. 1 -3 can have electrically Inactive arms configured to extend from the guide tubes 108a-b and a monopolar electrode and/or a chemical injection needle configured to extend between the arms.
- the approximating mechanism 1 10 can draw the guide tubes 1 G8a-b toward each other to move the electrically inactive arms closer together, as described above, and then (a) electrical energy can be applied to the tissue between the arms using the monopolar electrode and/or (b) a chemical shrinking agent can be applied to the tissue between the arms via the chemical injection needle.
- Mitral prolapse or regurgitation may be attributable to overly long chordae tendineae.
- the chordae tendineae are taut and linear during systole and become limp and tortuous during diastole it has been previously proposed to shorten chordae by applying energy to heat and shrink the chordae.
- Previous techniques involved placing an electrode against the chordae tendineae and applying energy until the chord shrinks appropriately. This is an uncontrolled method which may easily result in excessive shrinkage of a chord, which could end up“tethering” the leaflets and preventing closure of the valve. Moreover, it may be difficult to control the chords and to visualize how much shrinkage is occurring.
- SA-5D show a procedure for selectively and contro!lably heating and shrinking the chordae tendineae using a device 500 having energy delivery mechanisms 501 (identified individually as first energy delivery mechanism 501 a and second energy delivery mechanism 501 b).
- the first and second energy delivery mechanisms 501 a-b are configured to grasp one or more chordae in two places a certain distance apart.
- the energy delivery mechanisms 501 a-b can then be approximated by the desired length of shrinkage, and energy is then delivered between the energy delivery mechanisms 501 a-b to shrink the portion of the chordae between the energy delivery mechanisms 501 a-b.
- first energy delivery mechanism 501 a could be biased at one polarity and the second energy delivery mechanism 501 b could be biased at the opposite polarity such that the current flows through the region of the chordae between the first and second energy delivery mechanisms 501 a-b.
- FIGs. 5A-5D Referring to FIG. 5A, the first and second energy delivery mechanisms 501 a-b are initially close together, possibly at an oblique angle to the axis of the catheter to minimize their cross-sectional profile for delivery through a guide catheter 530.
- the energy delivery elements 501 a-b can have jaws 502a-b, respectively, configured to be: (a) open for receiving a chord; (b) partially closed to retain the chord while being able to slide along the chord; and (c) fully closed to grasp the chord to prevent the chord from sliding with respect to the jaws 502a-b.
- the first and second energy delivery mechanisms 501 a-b can be placed near each other at first region of a chord (FIG. 5A), and then the first energy delivery mechanism 501 a can be moved apart from the second energy delivery mechanism 501 b to space the first and second energy delivery mechanisms 501 a-b apart from each other along the chord (FIG. 5B).
- the first and second jaws 5Q2a-b can then be firmly clamped against the chord and the moved closer together (approximated) such that a certain amount of slack S is induced in the chord, as shown in FIG. 5C.
- Energy can then be applied between the first and second energy delivery mechanisms 501 a-b to preferentially and controllably shrink the chord in the longitudinal direction of the chord, as shown In FIG. 5D.
- the jaws 5G2a-b can be released (e.g., opened) to release the chord. Valve performance can then be re-assessed and, if needed, energy can be reapplied to further shrink the chord or other chords can be shrunk.
- the device 500 can be placed at the chords using a trans-apicai, trans- aortic, trans-atrial, or trans-septai approach.
- ultrasonic imaging especially 3-dimensional trans-esophageal imaging, will be very helpful in managing the procedure.
- This device could also be used in a surgical setting, with visual confirmation of the chord grasping and length to be shortened.
- the energy may be bipolar RF energy applied between the first and second jaws 502a-b, monopolar RF energy, laser energy, ultrasonic energy, resistive heating of the electrodes, microwave energy, or other energy modalities.
- Bipolar energy may have the advantage of directing energy to the tissue between the two jaws.
- a chemical agent e.g., phenol, glutaraldehyde or other fixative chemicals
- FIG. 6 illustrates some embodiments of the energy delivery mechanism 501 of the device 500 described above with reference to FIGs. 5A-5D.
- the energy delivery mechanism 501 has a jaw 502 with a first jaw portion 503a and a second jaw portion 503b, and the first and second jaw portions 503a ⁇ b include first and second electrical contacts 5Q4a-b, respectively, (identified collectively as“contacts 504”).
- Each of the first and second jaw portions 503a-b can have a shaft 5Q6a-b, respectively, and a grasping portion 5Q8a-b, respectively.
- the shafts 506a-b are configured to extend longitudinally along the length of the device and be manipulated to move the grasping portions 508a-b toward/away from each other.
- the shafts 506a-b and grasping portions 508a-b can be electrically conductive and coated with a dielectric material except for the areas of the contacts 504a-b
- the shafts S08a-b and grasping portions 50Sa-b can be made from a dielectric material with separate electrically conductive contacts 504a-b and wires in or on the shafts 506a-b.
- the energy delivery mechanism 501 can further include a coiled sleeve 522 through which the shafts 506a-b and grasping portions 5G8a-b can extend.
- the grasping portions 508a-b can be closed (e.g., clamped together) by sliding advancing the coiled sleeve 522 dista!ly toward the grasping portions 5Q8a-b or opened (e.g., moved apart) by sliding (retracting) the coiled sleeve proximally away from the grasping portions 508a-b.
- the grasping portions 5Q8a ⁇ b can accordingly extend from the shafts 5G6a-b along a smooth bend 5Q9a-b, respectively, to facilitate the closing and opening of the grasping portions 5G8a-b via movement of the coiled sleeve 522.
- the energy delivery mechanism may have only one of the electrical contacts 504a-b in some embodiments.
- a common polarity can be applied to both contacts 5Q4a-b in a single jaw 502 of one energy delivery mechanism 501.
- two energy delivery mechanisms 501 can be used as described above with respect to FIGs. 5A-5D to apply bipolar RF energy through a chord.
- a common electrode can be used instead of one of the energy delivery mechanisms 501 a-b.
- the contacts 5Q4a-b of a single energy delivery element 501 may by biased at opposite polarities to focus the energy in the region of a chord between the contacts 5Q4a-b
- Mitral valve regurgitation often happens because there is excess loose tissue in the posterior leaflet.
- Dr. Dwight McGoon of the Mayo Clinic developed a technique of excising a V-shaped section of the P2 section of the posterior leaflet free edge and sewing the cut edges together. More recently, surgeons have simply folded the excess tissue into the ventricle and sewed the edges of that section together without cutting the leaflets, a technique sometimes called a“foldoplasty” or“dunkop!asty.”
- Several attempts have been made to use RF energy to shrink the leaflets, but the existing techniques do not provide appropriate control of the directionality of the shrinkage.
- RF energy may modify the elastic modulus of the leaflet (e.g., make it stiffer) in a manner that may reduce the amount of prolapse.
- FIGs. 7A-7C show a device 600 for controlled shrinkage of leaflets via application of energy and/or through the application of a chemical agent.
- the device 600 includes a catheter 620 that can be introduced into the left atrium and two energy delivery arms 801 (identified individually as first and second arms 601 a and 601 b) having energy delivery elements 602 (identified individually as first and second energy delivery elements 602a and 602b).
- the energy delivery elements 602a- b can be configured to be pressed against a native leaflet of a heart valve, such as the posterior leaflet of a mitral valve, and each of the energy delivery elements 802a-b can include an electrode 604 and an aperture 606.
- the energy delivery elements 602a-b can be individually secured against the leaflet with suction transmitted through aperture 606.
- the energy delivery elements 602a-b can optionally include an extension 608 configured to wrap over the free edge of the leaflet and press the leaflet against the energy delivery element 602.
- the electrodes 604 can be flexible, such as an electrically conductive mesh, so that they can be securely held against the leaflet. (See, FIG. 7B.).
- the electrodes 604 can alternatively be a more rigid eiectricaiiy conductive element.
- the energy delivery elements 602 may further include a face 609 having surface features 609a such as roughness, serrations, small spikes, or the like which engage the tissue and prevent if from shrinking along the length of the electrode 604 while energy is delivered, as shown in FIG. 7B.
- the device 800 can further include an approximating mechanism 610 having a pull-wire system 61 1 designed to pull the two arms 601 together before applying energy, or to freely allow the arms 801 to move closer together as the tissue shrinks.
- the approximating mechanism can alternatively be any of the approximating mechanisms 1 10 described above with reference to F!Gs 2 and 3.
- the energy may be bipolar RF energy, monopolar RF energy, laser energy, ultrasonic energy, resistive heating of the electrodes, microwave energy, or other energy modalities.
- a chemical agent e.g., phenol, glutaraldehyde or other fixative chemicals
- FIG. 8 shows a device 700 having a pair of surgical forceps with pointed electrodes 702 on the tips which the surgeon can insert into the annular tissue.
- the electrodes 702 are used to approximate the tissue and to deliver energy.
- Electrodes 702 are eiecfricaily isolated from the forceps body 704 so that energy can be delivered between the electrodes 702.
- the electrodes 702 and arms 706 can be attached to a catheter or single- shafted instrument or the like (not illustrated), perhaps with a covering sleeve.
- the catheter or instrument shaft may be designed to be flushed to prevent the introduction of air into the bloodstream, and to prevent the backflow of blood out of the device in some embodiments, the catheter may have an overall shaft diameter of 3-10 m, and the shaft might be made flexible to accommodate varying surgical angles.
- the catheter can also be a disposable device or a reusable device. Similarly, the other concepts described above could be adapted to use in the surgical setting.
- the energy may be bipolar RF energy, monopolar RF energy, laser energy, ultrasonic energy, resistive heating of the electrodes, microwave energy, or other energy modalities
- a chemical agent e.g., phenol, glutaraldehyde or other fixative chemicals
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Surgery (AREA)
- Engineering & Computer Science (AREA)
- Plasma & Fusion (AREA)
- Medical Informatics (AREA)
- Otolaryngology (AREA)
- Physics & Mathematics (AREA)
- Cardiology (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Molecular Biology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Surgical Instruments (AREA)
- Laser Surgery Devices (AREA)
Abstract
Description
Claims
Priority Applications (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA3075537A CA3075537A1 (en) | 2018-09-14 | 2018-09-14 | Devices and methods for remodeling tissue |
PCT/US2018/051211 WO2020055433A1 (en) | 2018-09-14 | 2018-09-14 | Devices and methods for remodeling tissue |
US16/650,837 US20200275974A1 (en) | 2017-09-14 | 2018-09-14 | Devices and methods for remodeling tissue |
CN201880073987.6A CN113164199A (en) | 2018-09-14 | 2018-09-14 | Device and method for remodeling tissue |
JP2020515742A JP7332587B2 (en) | 2018-09-14 | 2018-09-14 | Tissue remodeling device and method |
EP18816290.3A EP3675761A1 (en) | 2018-09-14 | 2018-09-14 | Devices and methods for remodeling tissue |
AU2018440941A AU2018440941A1 (en) | 2017-09-14 | 2018-09-14 | Devices and methods for remodeling tissue |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/US2018/051211 WO2020055433A1 (en) | 2018-09-14 | 2018-09-14 | Devices and methods for remodeling tissue |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2020055433A1 true WO2020055433A1 (en) | 2020-03-19 |
Family
ID=64664373
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2018/051211 WO2020055433A1 (en) | 2017-09-14 | 2018-09-14 | Devices and methods for remodeling tissue |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP3675761A1 (en) |
JP (1) | JP7332587B2 (en) |
CN (1) | CN113164199A (en) |
AU (1) | AU2018440941A1 (en) |
CA (1) | CA3075537A1 (en) |
WO (1) | WO2020055433A1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2022097130A1 (en) * | 2020-11-08 | 2022-05-12 | Bio Refine Ltd. | Heart valve ablation catheter |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060189972A1 (en) * | 2005-02-02 | 2006-08-24 | Gynesonics, Inc. | Method and device for uterine fibroid treatment |
WO2008084244A2 (en) * | 2007-01-11 | 2008-07-17 | Emcision Limited | Device and method for the treatment of diseased tissue such as tumours |
US20110306851A1 (en) * | 2011-08-26 | 2011-12-15 | Jie Wang | Mapping sympathetic nerve distribution for renal ablation and catheters for same |
WO2014008489A1 (en) * | 2012-07-04 | 2014-01-09 | Cibiem, Inc. | Devices and systems for carotid body ablation |
EP3178516A1 (en) * | 2015-12-10 | 2017-06-14 | Biosense Webster (Israel) Ltd. | Stabilized spine electrophysiologic catheter |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6669687B1 (en) * | 1999-06-25 | 2003-12-30 | Vahid Saadat | Apparatus and methods for treating tissue |
CA2666712C (en) * | 2006-10-18 | 2015-03-31 | Asher Holzer | Filter assemblies |
-
2018
- 2018-09-14 CA CA3075537A patent/CA3075537A1/en not_active Abandoned
- 2018-09-14 AU AU2018440941A patent/AU2018440941A1/en not_active Abandoned
- 2018-09-14 EP EP18816290.3A patent/EP3675761A1/en active Pending
- 2018-09-14 WO PCT/US2018/051211 patent/WO2020055433A1/en unknown
- 2018-09-14 CN CN201880073987.6A patent/CN113164199A/en active Pending
- 2018-09-14 JP JP2020515742A patent/JP7332587B2/en active Active
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060189972A1 (en) * | 2005-02-02 | 2006-08-24 | Gynesonics, Inc. | Method and device for uterine fibroid treatment |
WO2008084244A2 (en) * | 2007-01-11 | 2008-07-17 | Emcision Limited | Device and method for the treatment of diseased tissue such as tumours |
US20110306851A1 (en) * | 2011-08-26 | 2011-12-15 | Jie Wang | Mapping sympathetic nerve distribution for renal ablation and catheters for same |
WO2014008489A1 (en) * | 2012-07-04 | 2014-01-09 | Cibiem, Inc. | Devices and systems for carotid body ablation |
EP3178516A1 (en) * | 2015-12-10 | 2017-06-14 | Biosense Webster (Israel) Ltd. | Stabilized spine electrophysiologic catheter |
Non-Patent Citations (1)
Title |
---|
TOMASZ A. TIMEK ET AL.: "Ablation of mitral annular and leaflet muscle: effects on annular and leaflet dynamics", AMERICAN JOURNAL OF PHYSIOLOGY, 1 October 2003 (2003-10-01), Retrieved from the Internet <URL:https://doi.org/10.1152/ajpheart.00179.2003> |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2022097130A1 (en) * | 2020-11-08 | 2022-05-12 | Bio Refine Ltd. | Heart valve ablation catheter |
Also Published As
Publication number | Publication date |
---|---|
CN113164199A (en) | 2021-07-23 |
EP3675761A1 (en) | 2020-07-08 |
JP2022520135A (en) | 2022-03-29 |
AU2018440941A1 (en) | 2020-04-30 |
JP7332587B2 (en) | 2023-08-23 |
CA3075537A1 (en) | 2020-03-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20200275974A1 (en) | Devices and methods for remodeling tissue | |
EP3541295B1 (en) | System for heart valve leaf repair | |
CA2586512C (en) | Fixation devices for variation in engagement of tissue | |
CA2494758C (en) | Cardiac devices and methods for minimally invasive repair of ischemic mitral regurgitation | |
JP5844406B2 (en) | Heart valve downsizing apparatus and method | |
EP1176913B1 (en) | Methods and apparatus for cardiac valve repair | |
JP5848125B2 (en) | Suture device and method for suturing anatomic valves | |
US8216230B2 (en) | Cardiac valve leaflet attachment device and methods thereof | |
US20070239154A1 (en) | Activation device for dynamic ring manipulation | |
US11850151B2 (en) | Proximal element actuator fixation and release mechanisms | |
US20210346045A1 (en) | Leaflet grasping and cutting device | |
AU2017445624A1 (en) | Multiple-stage grinding circuit | |
US20220168014A1 (en) | Systems, apparatuses, and methods for removing a medical implant from cardiac tissue | |
JP7332587B2 (en) | Tissue remodeling device and method | |
US10702252B2 (en) | Device and method for transcatheter heart valve repair under triangular resection technique | |
CN109700490B (en) | Suturing device |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
ENP | Entry into the national phase |
Ref document number: 2020515742 Country of ref document: JP Kind code of ref document: A |
|
ENP | Entry into the national phase |
Ref document number: 3075537 Country of ref document: CA Kind code of ref document: A |
|
ENP | Entry into the national phase |
Ref document number: 2018816290 Country of ref document: EP Effective date: 20200331 |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 18816290 Country of ref document: EP Kind code of ref document: A1 |
|
ENP | Entry into the national phase |
Ref document number: 2018440941 Country of ref document: AU Date of ref document: 20180914 Kind code of ref document: A |
|
NENP | Non-entry into the national phase |
Ref country code: DE |